1. Home
  2. WST vs CBOE Comparison

WST vs CBOE Comparison

Compare WST & CBOE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WST
  • CBOE
  • Stock Information
  • Founded
  • WST 1923
  • CBOE 1973
  • Country
  • WST United States
  • CBOE United States
  • Employees
  • WST N/A
  • CBOE N/A
  • Industry
  • WST Medical/Dental Instruments
  • CBOE Investment Bankers/Brokers/Service
  • Sector
  • WST Health Care
  • CBOE Finance
  • Exchange
  • WST Nasdaq
  • CBOE Nasdaq
  • Market Cap
  • WST 15.6B
  • CBOE 23.7B
  • IPO Year
  • WST N/A
  • CBOE 2010
  • Fundamental
  • Price
  • WST $227.12
  • CBOE $235.29
  • Analyst Decision
  • WST Buy
  • CBOE Hold
  • Analyst Count
  • WST 7
  • CBOE 14
  • Target Price
  • WST $331.67
  • CBOE $224.71
  • AVG Volume (30 Days)
  • WST 646.1K
  • CBOE 624.2K
  • Earning Date
  • WST 07-24-2025
  • CBOE 08-01-2025
  • Dividend Yield
  • WST 0.37%
  • CBOE 1.07%
  • EPS Growth
  • WST N/A
  • CBOE 2.12
  • EPS
  • WST 6.37
  • CBOE 7.62
  • Revenue
  • WST $2,895,800,000.00
  • CBOE $4,332,300,000.00
  • Revenue This Year
  • WST $3.38
  • CBOE N/A
  • Revenue Next Year
  • WST $5.85
  • CBOE $4.18
  • P/E Ratio
  • WST $35.63
  • CBOE $30.90
  • Revenue Growth
  • WST N/A
  • CBOE 15.76
  • 52 Week Low
  • WST $187.43
  • CBOE $168.16
  • 52 Week High
  • WST $352.33
  • CBOE $237.27
  • Technical
  • Relative Strength Index (RSI)
  • WST 59.84
  • CBOE 60.85
  • Support Level
  • WST $219.60
  • CBOE $230.26
  • Resistance Level
  • WST $233.84
  • CBOE $237.27
  • Average True Range (ATR)
  • WST 5.29
  • CBOE 4.82
  • MACD
  • WST 0.60
  • CBOE 0.40
  • Stochastic Oscillator
  • WST 66.82
  • CBOE 85.58

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

About CBOE Cboe Global Markets Inc.

Cboe Global Markets Inc is a provider of market infrastructure and tradable products, that delivers cutting-edge trading, clearing, and investment solutions to market participants around the world. The Company is committed to operating a trusted, inclusive all over world marketplace, and to providing products, technology, and data solutions that enable participants to define a sustainable financial future. Cboe provides trading solutions and products in multiple asset classes, including equities, derivatives, FX, and digital assets, across North America, Europe, and Asia Pacific.

Share on Social Networks: